
A new, first-of-its-kind tablet offering relief from severe dust mite allergies has been approved for NHS use, potentially benefiting thousands.
The National Institute for Health and Care Excellence (Nice) has given the green light to 12 SQ-HDM SLIT, also known as Acarizax, for individuals aged 12 to 65 suffering from persistent moderate to severe house dust mite allergic rhinitis.